Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A Trimodal Imaging Platform for Tracking Viable Transplanted Pancreatic Islets In Vivo: F-19 MR, Fluorescence, and Bioluminescence Imaging

A. Gálisová, V. Herynek, E. Swider, E. Sticová, A. Pátiková, L. Kosinová, J. Kříž, M. Hájek, M. Srinivas, D. Jirák,

. 2019 ; 21 (3) : 454-464. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023920
E-zdroje Online Plný text

NLK ProQuest Central od 2005-01-01 do 2019-01-31
Medline Complete (EBSCOhost) od 2011-02-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 2005-01-01 do 2019-01-31
Health & Medicine (ProQuest) od 2005-01-01 do 2019-01-31

PURPOSE: Combining specific and quantitative F-19 magnetic resonance imaging (MRI) with sensitive and convenient optical imaging provides complementary information about the distribution and viability of transplanted pancreatic islet grafts. In this study, pancreatic islets (PIs) were labeled with positively charged multimodal nanoparticles based on poly(lactic-co-glycolic acid) (PLGA-NPs) with encapsulated perfluoro-15-crown-5-ether and the near-infrared fluorescent dye indocyanine green. PROCEDURES: One thousand and three thousand bioluminescent PIs were transplanted into subcutaneous artificial scaffolds, which served as an alternative transplant site. The grafts were monitored using in vivo F-19 MR, fluorescence, and bioluminescence imaging in healthy rats for 2 weeks. RESULTS: Transplanted PIs were unambiguously localized in the scaffolds by F-19 MRI throughout the whole experiment. Fluorescence was detected in the first 4 days after transplantation only. Importantly, in vivo bioluminescence correlated with the F-19 MRI signal. CONCLUSIONS: We developed a trimodal imaging platform for in vivo examination of transplanted PIs. Fluorescence imaging revealed instability of the fluorescent dye and its limited applicability for longitudinal in vivo studies. A correlation between the bioluminescence signal and the F-19 MRI signal indicated the fast clearance of PLGA-NPs from the transplantation site after cell death, which addresses a major issue with intracellular imaging labels. Therefore, the proposed PLGA-NP platform is reliable for reflecting the status of transplanted PIs in vivo.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023920
003      
CZ-PrNML
005      
20220329145400.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11307-018-1270-3 $2 doi
035    __
$a (PubMed)30167995
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gálisová, A $u MR Unit, Department of Radiodiagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
245    12
$a A Trimodal Imaging Platform for Tracking Viable Transplanted Pancreatic Islets In Vivo: F-19 MR, Fluorescence, and Bioluminescence Imaging / $c A. Gálisová, V. Herynek, E. Swider, E. Sticová, A. Pátiková, L. Kosinová, J. Kříž, M. Hájek, M. Srinivas, D. Jirák,
520    9_
$a PURPOSE: Combining specific and quantitative F-19 magnetic resonance imaging (MRI) with sensitive and convenient optical imaging provides complementary information about the distribution and viability of transplanted pancreatic islet grafts. In this study, pancreatic islets (PIs) were labeled with positively charged multimodal nanoparticles based on poly(lactic-co-glycolic acid) (PLGA-NPs) with encapsulated perfluoro-15-crown-5-ether and the near-infrared fluorescent dye indocyanine green. PROCEDURES: One thousand and three thousand bioluminescent PIs were transplanted into subcutaneous artificial scaffolds, which served as an alternative transplant site. The grafts were monitored using in vivo F-19 MR, fluorescence, and bioluminescence imaging in healthy rats for 2 weeks. RESULTS: Transplanted PIs were unambiguously localized in the scaffolds by F-19 MRI throughout the whole experiment. Fluorescence was detected in the first 4 days after transplantation only. Importantly, in vivo bioluminescence correlated with the F-19 MRI signal. CONCLUSIONS: We developed a trimodal imaging platform for in vivo examination of transplanted PIs. Fluorescence imaging revealed instability of the fluorescent dye and its limited applicability for longitudinal in vivo studies. A correlation between the bioluminescence signal and the F-19 MRI signal indicated the fast clearance of PLGA-NPs from the transplantation site after cell death, which addresses a major issue with intracellular imaging labels. Therefore, the proposed PLGA-NP platform is reliable for reflecting the status of transplanted PIs in vivo.
650    _2
$a zvířata $7 D000818
650    _2
$a endocytóza $7 D004705
650    _2
$a fluorescence $7 D005453
650    _2
$a fluor $x chemie $7 D005461
650    _2
$a Langerhansovy ostrůvky $x diagnostické zobrazování $7 D007515
650    12
$a transplantace Langerhansových ostrůvků $7 D016381
650    12
$a luminiscenční měření $7 D008163
650    12
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a modely u zvířat $7 D023421
650    12
$a molekulární zobrazování $7 D057054
650    _2
$a potkani inbrední LEW $7 D011917
650    _2
$a potkani transgenní $7 D055647
650    _2
$a tkáňové podpůrné struktury $x chemie $7 D054457
650    _2
$a přežití tkáně $7 D014022
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Herynek, V $u MR Unit, Department of Radiodiagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Center for Advanced Preclinical Imaging, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Swider, E $u Department of Tumor Immunology, Radboud University Medical Center, Nijmegen, Netherlands.
700    1_
$a Sticová, E $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Department of Pathology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Pátíková, Alžběta, $u Centre of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $d 1990- $7 xx0271325
700    1_
$a Kosinová, L $u Centre of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Kříž, J $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Hájek, M $u MR Unit, Department of Radiodiagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Srinivas, M $u Department of Tumor Immunology, Radboud University Medical Center, Nijmegen, Netherlands.
700    1_
$a Jirák, D $u MR Unit, Department of Radiodiagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. daniel.jirak@ikem.cz. Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. daniel.jirak@ikem.cz.
773    0_
$w MED00008643 $t Molecular imaging and biology $x 1860-2002 $g Roč. 21, č. 3 (2019), s. 454-464
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30167995 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20220329145357 $b ABA008
999    __
$a ok $b bmc $g 1596239 $s 1114596
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 21 $c 3 $d 454-464 $e - $i 1860-2002 $m Molecular imaging and biology $n Mol Imaging Biol $x MED00008643
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...